Japanese scientists have achieved a groundbreaking milestone by using CRISPR gene-editing technology to remove the extra chromosome that causes Down syndrome. Led by Dr. Ryotaro Hashizume, the team successfully restored normal function in human cells with a success rate of over 30%. This world-first breakthrough offers new hope for developing future therapies that directly address the genetic root of the condition.
